Kinexions is a newsletter written by individuals in the Kinexum community that highlights current events in the pharmaceutical and medical device industries.
A NOTE FROM KINEXUM’S FOUNDER AND EXECUTIVE CHAIRMAN by ZAN FLEMING, MD, Executive Chairman of Kinexum
A NOTE FROM THE CEO by THOMAS SEOH, JD, CEO of Kinexum
GLP-1 AND AMYLIN: A THERAPEUTIC REVOLUTION IN DIABETES AND OBESITY IN PROGRESS by OLIVIER SOULA, PhD, CEO and Co-Founder of Adocia
DESPERATELY NEEDED: DIFFERENT RISK-BENEFIT CALCULATIONS FOR CHRONIC PROGRESSIVE DISEASES by STEVEN GROSSMAN, JD, President of HPS Group
JANICE SORETH — A CAREER DEDICATED TO INNOVATION AND SERVICE by ZAN FLEMING, MD, Executive Chairman of Kinexum and JANICE SORETH, MD, Scientific Consultant at Kinexum
OBESITY PHARMACOTHERAPY: NEW ERA, NEW OPPORTUNITIES? PART 2 by MICHAEL ZEMEL, PhD, Chief Scientific Officer of Kinexum
HOW MEDICAL DEVICE CONTROL HELPS THE STARTUP by EDWIN WALDBUSSER, Medical Device Regulatory Consultant at Kinexum
A BIOGRAPHICAL INTERVIEW WITH KINEXUM FOUNDER AND EXECUTIVE CHAIRMAN featuring ZAN FLEMING, MD, Executive Chairman of Kinexum
GROUNDWORD FOR DRAFT HEALTHSPAN LEGISLATION AT METABESITY 2022 by GEORGINA XANTHOU, Scientific Consultant at Kinexum
THE THRILL OF THE CHILL by KRISTI HULTBERG, Executive Business Administrator at Kinexum
OBESITY PHARMACOTHERAPY: NEW ERA, NEW OPPORTUNITIES? by MICHAEL ZEMEL, PhD, Chief Scientific Officer of Kinexum
LIFE AND WORK IN THE EVOLUTIONARY PHARMA INDUSTRY by KNUT ZELLERHOFF, PhD, CMC Consultant at Kinexum
WEBINAR RECAP: BIG DATA HEALTH, COVID-19 AND LONGEVITY by BRONTE JENKINS, Senior Associate at Kinexum
WEBINAR RECAP: WOW OR YEOW?! FDA OUTLOOK FOR 2022 AND BEYOND by BRONTE JENKINS, Senior Associate at Kinexum
CLARIFYING REGULATORY PATHWAYS FOR LONGEVITY PRODUCTS by THOMAS SEOH, JD, CEO of Kinexum and BRONTE JENKINS, Senior Associate at Kinexum
EVOLVING COMMERCIALIZATION: TARGETING METABESITY TRANSCRIPT EXCERPT by BRONTE JENKINS, Senior Associate at Kinexum
FIRESIDE CHATS WITH STEPHEN HAHN, MD AND ERIC TOPOL, MD by BRONTE JENKINS, Senior Associate at Kinexum
THE FORT COLLINS CONNECTION by KATE NORTON, PhD, Consultant at Kinexum and ANN DONOGHUE, DVM, Consultant at Kinexum
ARTIFICIAL INTELLIGENCE IN DIAGNOSTIC IMAGING by CRAIG SHERMAN, MD, MHA, Consultant at Kinexum
THE AMAZING CAREER OF DR. JAY SKYLER AND HIS THOUGHTS ABOUT THE FUTURE featuring JAY SKYLER, MD, MACP, Professor of Medicine, Pediatrics and Psychology at University of Miami
EARLY DEVELOPMENT ISSUES FACED BY NEARLY ALL EMERGING LIFE SCIENCE COMPANIES by SAM COLLAUDIN, PhD, JMBA, Business Strategy Consultant at Kinexum and THOMAS SEOH, JD, CEO of Kinexum
LEST WE FORGET: BRIEF MEMOIRS FROM A SEPTUAGENARIAN by ADRIANE BERG, JD, former Executive Director of the Kitalys Institute
HOW THE COVID PANDEMIC IS TRANSFORMING CLINICAL RESEARCH & DEVELOPMENT by PETER LENEHAN, MD, PhD, Oncology Consultant at Kinexum
ONCOLOGY THERAPEUTIC DEVELOPMENT TODAY: OVERCOMING THE CHALLENGES OF CANCER WITH SCIENCE by JERRY HUANG, MD, PhD, Oncology Consultant at Kinexum
ALZHEIMER’S DISEASE, A NEW LABEL EXTENSION FOR DIABETES DRUGS? by SAM COLLAUDIN, PhD, JMBA, Business Strategy Consultant at Kinexum
THE KITALYS INSTITUTE: TAKING THE MOONSHOT FOR A NATIONAL POLICY ON INCREASED HEALTHSPAN FOR ALL by ADRIANE BERG, JD, former Executive Director of the Kitalys Institute
SYMPOSIUM SUMMARY: DEFINING A NATIONAL RESEARCH VISION TARGETING THE BIOLOGY OF AGING by ELIJAH ABASS, former Associate at Kinexum
WEBINAR RECAP: THE DOG AGING PROJECT by BRONTE JENKINS, Associate at Kinexum
INTERVIEW WITH DR. SAM COLLAUDIN featuring SAM COLLAUDIN, PhD, JMBA, Business Strategy Consultant at Kinexum
DIETARY GUIDELINES FOR AMERICANS 2020 – 2025: WE’RE NOT THERE YET… by MICHAEL ZEMEL, PhD, Chief Scientific Officer of Kinexum
INTERVIEW WITH DR. ALEX ZHAVORONKOV featuring ALEX ZHAVORONKOV, PhD, Founder and CEO of InSilico Medicine
CONFERENCE RECAP: CVCT’S INCREASING HEALTHSPAN SESSION by ELIJAH ABASS, former Associate at Kinexum
WEBINAR RECAP: MITOCHONDRIA, AGING, AND HEALTH by BRONTE JENKINS, Associate at Kinexum
WEBINAR RECAP: WOW OR YEOW?! FDA OUTLOOK FOR 2021 AND BEYOND by BRONTE JENKINS, Associate at Kinexum
WEBINAR RECAP: WHY AND HOW CAN AGING SLOW THE AGING PROCESS? by ELIJAH ABASS, former Associate at Kinexum
HOW DOES “OPERATION WARP SPEED” VACCINE DEVELOPMENT COMPARE TO “REGULAR” VACCINE DEVELOPMENT? by C. JO WHITE, MD, FIDSA, Clinical Development Consultant at Kinexum
MY ADVENTURES WITH GROWTH HORMONE by GORDON CUTLER, JR, MD, Clinical Development Consultant at Kinexum
GSA PRE-CONFERENCE WORKSHOP Q&A
INTERVIEW WITH DR. NIR BARZILAI featuring NIR BARZILAI, MD, Director of the Institute for Aging Research at Albert Einstein College of Medicine
FDA UPDATE by BRIAN E. HARVEY, MD, PhD, Senior Consultant in Clinical Development at Kinexum and former Director of FDA’s Division of Gastroenterology Products